ANKAWI, G., Xie, Y., Yang, B., Garzotto, F., Passannante, A., Breglia, A., . . . Ronco, C. (2019). SAT-128 TISSUE INHIBITOR METALLOPROTEINASE-2 (TIMP-2) • IGF-BINDING PROTEIN-7 (IGFBP7) LEVELS ARE ASSOCIATED WITH ADVERSE OUTCOMES IN ICU PATIENTS WITH AKI. Kidney international reports, 4(7), S58-S59. https://doi.org/10.1016/j.ekir.2019.05.158
Chicago-Zitierstil (17. Ausg.)ANKAWI, G., et al. "SAT-128 TISSUE INHIBITOR METALLOPROTEINASE-2 (TIMP-2) • IGF-BINDING PROTEIN-7 (IGFBP7) LEVELS ARE ASSOCIATED WITH ADVERSE OUTCOMES IN ICU PATIENTS WITH AKI." Kidney International Reports 4, no. 7 (2019): S58-S59. https://doi.org/10.1016/j.ekir.2019.05.158.
MLA-Zitierstil (9. Ausg.)ANKAWI, G., et al. "SAT-128 TISSUE INHIBITOR METALLOPROTEINASE-2 (TIMP-2) • IGF-BINDING PROTEIN-7 (IGFBP7) LEVELS ARE ASSOCIATED WITH ADVERSE OUTCOMES IN ICU PATIENTS WITH AKI." Kidney International Reports, vol. 4, no. 7, 2019, pp. S58-S59, https://doi.org/10.1016/j.ekir.2019.05.158.